Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 159

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Anti‐angiogenic drugs: from bench to clinical trials

Quesada, Ana R., Muñoz‐Chápuli, Ramón, Medina, Miguel A.·2006·Medicinal Research Reviews

Abstract

Angiogenesis, the generation of new capillaries through a process of pre‐existing microvessel sprouting, is under stringent control and normally occurs only during embryonic and post‐embryonic development, reproductive cycle, and wound repair. However, in many pathological conditions (solid tumor progression, metastasis, diabetic retinopathy, hemangioma, arthritis, psoriasis and atherosclerosis among others), the disease appears to be associated with persistent upregulated angiogenesis. The development of specific anti‐angiogenic agents arises as an attractive therapeutic approach for the treatment of cancer and other angiogenesis‐dependent diseases. The formation of new blood vessels is a complex multi‐step process. Endothelial cells resting in the parent vessels are activated by an angiogenic signal and stimulated to synthesize and release degradative enzymes allowing endothelial cells to migrate, proliferate and finally differentiate to give rise to capillary tubules. Any of these steps may be a potential target for pharmacological intervention. In spite of the disappointing results obtained initially in clinical trials with anti‐angiogenic drugs, recent reports with positive results in phases II and III trials encourage expectations in their therapeutic potential. This review discusses the current approaches for the discovery of new compounds that inhibit angiogenesis, with emphasis on the clinical developmental status of anti‐angiogenic drugs. © 2006 Wiley Periodicals, Inc. Med Res Rev, 26, No. 4, 483–530, 2006

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/med.20059

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 159

Metadata

Authors
Quesada, A. R., Muñoz‐Chápuli, R., & Medina, M. A.
Venue
Medicinal Research Reviews
Publisher
Wiley
Published
2006-05
Volume
26
Issue
4
Pages
483-530
ISSN
  • 0198-6325 (ISSN-L)
  • 1098-1128
OpenAlex
W2167139020
Cited by
159
References
13
FWCI
5.53
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti‐angiogenic drugs: from bench to clinical trials. https://app.cochat.ai/papers/10.1002/med.20059
The paper
Quesada, A. R., Muñoz‐Chápuli, R., & Medina, M. A. (2006). Anti‐angiogenic drugs: from bench to clinical trials. Medicinal Research Reviews. https://doi.org/10.1002/med.20059

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.